Suzy Davis

Suzy is a partner in the Private Equity group. She advises private equity funds, companies and management teams on domestic and cross-border corporate transactions. Suzy also has experience acting on general M&A transactions for private companies and venture capital investments, particularly in the life sciences and healthcare sectors.

Suzy has regularly worked on deals that have required her to manage, organise and co-ordinate multiple jurisdictions and which have required the implementation of complicated transaction structures.

CV ansehen CV ausblenden

Karriere

Since 2022	Partner, Taylor Wessing
2017 - 2022	Senior Associate, Taylor Wessing
2016 - 2017	Associate, Taylor Wessing

2012 - 2015	Associate, Hogan Lovells International
2010 - 2012	Trainee, Hogan Lovells International

Mehr Weniger

Ausbildung

2012	Admitted as a lawyer, England & Wales
2009	LPC , The College of Law, London
2008	LLB Law, University of Warwick

Mitgliedschaften

British Private Equity & Venture Capital Association

Expertise

Branchen Consumer Goods & Retail

Referenzen

Inflexion Private Equity	Advising Inflexion Private Equity on the sale of portfolio group, Glide.
Rutland Partners on its acquisition of Hereford Contract Canning	Our longstanding client, Rutland Partners acquired Hereford Contract Canning. HCC is the largest contract canning provider in the UK.
Affirma Capital on its MBO of Standard Chartered Bank's private equity investment business	Affirma Capital, a newly formed, independent private equity firm owned and managed by the former senior leadership of Standard Chartered Private Equity (SCPE), on its MBO of Standard Chartered Bank's (SCB) private equity investment business. The deal was complex, involving the acquisition by Affirma Capital of the general partners and investment managers of various third party funds being spun out from within SCB, as well as the establishment of a new fund backed by ICG and incorporation of investment adviser entities in Affirma Capital's key jurisdictions.

Apotex's EUR74m sale of subsidiaries to Aurobindo	Apotex on the sale of six European subsidiaries in Belgium, Poland, the Netherlands, Czech Republic and Spain, to Aurobindo for EUR74 million. This highly complex transaction involved the share transfer of subsidiaries in multiple jurisdictions being co-ordinated and managed by our UK team. We simultaneously advised on a multitude of business separation, ongoing product supply agreements and IP licences for the European business to continue operating after being removed from the Apotex group.
The management team of The Access Group on their reinvestment into the group	The Access Group is a leading provider of business management software to UK mid-market organisations. The group was previously owned by the management team and TA Associates. We advised the management team on their reinvestment into the group, which gives the company an enterprise value of GBP1bn.
Inflexion Private Equity on the refinancing of the Alston Elliot group	Inflexion Private Equity on the refinancing of the Alston Elliot group. Alston Elliot is a leading provider of premium data-driven graphics solutions for live sports broadcasts. The refinancing completed via secured loan facilities provided by Cordet Capital.